BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial

1. Bockorny, B.
2. Semenisty, V.
3. Macarulla, T.
4. Borazanci, E.
5. Wolpin, B.M.
6. Stemmer, S.M.
7. Golan, T.
8. Geva, R.
9. Borad, M.J.
10. Pedersen, K.S.
11. Park, J.O.
12. Ramirez, R.A.
13. Abad, D.G.
14. Feliu, J.
15. Muñoz, A.
16. Ponz-Sarvise, M.
17. Peled, A.
18. Lustig, T.M.
19. Bohana-Kashtan, O.
20. Shaw, S.M.
21. Sorani, E.
22. Chaney, M.
23. Kadosh, S.
24. Vainstein Haras, A.
25. Von Hoff, D.D.
26. Hidalgo, M.
27. Show all authors +